
|Articles|August 18, 2009
Amarex Selects OmniComm to Provide eClinical Solutions
Advertisement
Mid-Atlantic based Contract Research Organization (CRO), to provide the company with eClinical solutions for an upcoming Phase III trial.
The trial will be investigating the use of a medical device for wound healing. The study will be conducted at over 30 sites and will recruit up to 300 patients over the course of two years.
Amarex also joins OmniComm’s CRO Preferred Program, which will allow them to offer OmniComm’s electronic data capture solution, TrialMaster, to their clients.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
2
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
3
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
4
ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial
5



